StockData
CapsoVision, Inc logo

CapsoVision, Inc (CV) stock

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30383% above fair value
$6.03−0.24 (-3.83%)

Close on Nov 13, 2026Market cap $301.78MP/E –Yield –

CapsoVision price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CapsoVision's price to sales ratio was 22.6× on Nov 11, 2026, against 20.0× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202622.6×−15.6
2025Dec 31, 202538.2×–

More CapsoVision figures

See a number that looks wrong?